Booming antibodies 2001
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Ionis and AstraZeneca Close Deal to Develop and Commercialize Eplontersen

Thursday, December 30, 2021

Ionis Pharmaceuticals Inc the leader in RNAtargeted therapies today announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen Ionis investigational antisense medicine for the treatment of transthyr...

Amphastar Receives FDA Tentative Approval for Vasopressin

Thursday, December 30, 2021

Amphastar Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has tentatively approved the Companys Abbreviated New Drug Application ANDA for Vasopressin injection USP UnitsmL mL Single Dose Vial Vasopressin is indicated to in...

Novo Nordisk announces completion of Dicerna Pharmaceuticals acquisition

Wednesday, December 29, 2021

Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals Dicerna announced on November has been completed Following the expiration of Novo Nordisks cash tender offer for Dicerna Novo Nordisk has today acquired all outstanding sh...

WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

Tuesday, December 28, 2021

WuXi Biologics a global company with leading openaccess biologics technology platforms and ImmuneOncia Therapeutics Inc a clinicalstage immunooncology company in South Korea today announced that a Memorandum of Understanding MOU was signed to form a...

Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)

Monday, December 27, 2021

Amador Bioscience a global translational sciences and clinical pharmacology CRO announced today that it has completed the acquisition of Ann Arbor Pharmacometrics Group APG a premier pharmacometrics consulting firm based in Ann Arbor Michigan Amador...

Sedana Medical receives IND approval for US trial

Friday, December 24, 2021

Sedana Medical AB announces that the company has received Investigational New Drug IND clearance from the US Food and Drug Administration FDA to initiate phase III pivotal clinical trials with its Sedaconda products in the United States Sedana Medica...

Novavax and SK bioscience Expand Manufacturing Agreement

Friday, December 24, 2021

Novavax Inc a biotechnology company dedicated to developing and commercializing nextgeneration vaccines for serious infectious diseases and SK bioscience Co Limited a vaccine business subsidiary of Koreabased SK Group today announced the expansion of...

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Thursday, December 23, 2021

Pfizer Inc announced today that the US Food and Drug Administration FDA has authorized the emergency use of PAXLOVID nirmatrelvir PF tablets and ritonavir tablets for the treatment of mildtomoderate COVID in adults and pediatric patients years of ag...

Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

Thursday, December 23, 2021

Karyopharm Therapeutics Inc a commercialstage pharmaceutical company pioneering novel cancer therapies and the Menarini Group Menarini a privatelyheld leading international pharmaceutical company today announced their entry into an exclusive licensin...

Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

Wednesday, December 22, 2021

Karyopharm Therapeutics Inc a commercialstage pharmaceutical company pioneering novel cancer therapies and the Menarini Group Menarini a privatelyheld leading international pharmaceutical company today announced their entry into an exclusive licensin...

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA